Cutera (NASDAQ:CUTR) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a report published on Monday morning. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Performance

NASDAQ CUTR opened at $0.41 on Monday. Cutera has a one year low of $0.28 and a one year high of $3.73. The company has a 50-day simple moving average of $0.39 and a 200-day simple moving average of $0.74. The firm has a market capitalization of $8.28 million, a PE ratio of -0.06 and a beta of 1.31.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cutera stock. Squarepoint Ops LLC raised its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 164.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 113,964 shares of the medical device company’s stock after purchasing an additional 70,870 shares during the period. Squarepoint Ops LLC owned 0.57% of Cutera worth $172,000 at the end of the most recent quarter. 90.70% of the stock is owned by institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.